The FDA Just Approved the First Smart Pill – What Does This Mean for Clinical Trials?
Digital pills and other mHealth technologies can improve patient adherence, reduce costs, and shorten enrollment timelines for clinical trials.
What is the FDA’s Digital Health Action Plan, and What Does it Mean for Clinical Trials?
New guidelines from the FDA give clinical trials concrete recommendations on mHealth for today and confidence for the future.
New Study Reveals Reason for Lack of Minority Participation in Clinical Trials
What’s the largest barrier to clinical trial participation for minority patients? You might be surprised.
Factoring Socioeconomic and Cultural Considerations Into Clinical Trial Recruitment Strategies
In order to bolster clinical trial diversity, we first have to understand the existing barriers that prevent it.
FDA Spearheading New Efforts to Improve Patient Enrollment in Clinical Trials
The FDA is recognizing the importance of patient engagement in the clinical trial enrollment process – it’s time the industry followed suit.
Measuring the ROI of Patient Centricity in Clinical Trials
Patient centricity has become a best practice for the clinical trial industry – but how do you go about measuring the return on patient engagement?
Using Dynamic Digital Content to Encourage Clinical Trial Participation
In order to bolster clinical research awareness and participation, trials need to invest in dynamic content marketing and digital advertising.
New Survey Highlights Need for Better Patient Engagement in Clinical Trials
A new survey indicates that when it comes to patient engagement in clinical research, there’s still a lot of room for improvement.
Roundtable On Rare Disease Clinical Trials Highlights Industry’s Unique Challenges
If rare disease clinical trials want to recruit patients more effectively, they need to embrace innovative digital technologies.
